Natera's EXPAND Trial Enrollment Crosses 2,000 Patient Milestone
NTRA's EXPAND trial for Fetal Focus single-gene NIPT tops 2,000 patients, doubling in a year as new data spotlight its robust design.
Open original sourceLoading market dashboard
NTRA's EXPAND trial for Fetal Focus single-gene NIPT tops 2,000 patients, doubling in a year as new data spotlight its robust design.
Open original source